EUR 162.24 For Business Accounts Only

Enzon Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Synopsis

Enzon Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Summary

- Detailed information on Enzon Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Enzon Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Enzon Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Enzon Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Enzon Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

- Gain understanding of Enzon Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Enzon Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Enzon Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Key Highlights

Enzon Pharmaceuticals (Enzon or 'the company'), a biotechnology company, receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products. The company is headquartered in Piscataway, New Jersey, and employed one person as on December 31, 2014.